In early stage ovarian cancer, the fall in serum albumin likely results from metabolic factors secreted by ovarian cells, including interleukin-6 (IL-6), an inflammatory cytokine that inhibits the synthesis of albumin by hepatocytes and promotes the metastasis of ovarian cancer cells [[26]] [[27]]. This evidence concerns the gene ALB and ovarian carcinoma.